Galaxy Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
799 Ames Ave, Milpitas, California, 9503...Website
www.galaxytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Galaxy Therapeutics
Galaxy Therapeutics is a clinical-phase startup focused on revolutionizing the treatment of brain aneurysms through innovative solutions inspired by nature. Their flagship product, the SEAL Embolization System, is a dual-layer intrasaccular flow diverter designed for various types of aneurysms. The company is led by experienced neurointerventionalists and supported by a team of engineers and neurovascular experts, all dedicated to transforming patients' lives. Their products are currently limited to investigational use and are not approved for sale in Europe or the US.Explore more
Galaxy Therapeutics Org Chart
MA
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Galaxy Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Galaxy Therapeutics has new funding data
Check if Galaxy Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Galaxy Therapeutics is spiking on competitors!
Earning: See what the market has to say on Galaxy Therapeutics recently announced quarterly report
Product Launch: Get notified when Galaxy Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Galaxy Therapeutics
Click to see if Galaxy Therapeutics had a recent Job posting/layoffs
Galaxy Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Galaxy Therapeutics
Find more new buyers
Compare Similar Companies to Galaxy Therapeutics
Compare insights from companies similar to Galaxy Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Galaxy Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Galaxy Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Galaxy Therapeutics.
Galaxy Therapeutics Tech Stack
A closer look at the technologies used by Galaxy Therapeutics
See more technologies
Galaxy Therapeutics News & Media
Galaxy Therapeutics Submits Final Module of PMA to U.S. FDA for SEAL™ Device in Wide-Neck Bifurcation Aneurysms
MILPITAS, Calif., April 27, 2026 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the submission of its final module of its Premarket Approval (PMA) application to the U.S. Food and Drug...Galaxy Therapeutics Completes Enrollment in Pivotal SEAL IT IDE Trial
MILPITAS, Calif., Dec. 23, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced it has successfully completed enrollment in SEAL IT, its U.S. IDE trial evaluating the SEAL device for brain...Galaxy Therapeutics Appoints Neurovascular Industry Expert, Dr. Michael Alexander, as Chief Medical Officer
Newest Addition in Line with the Company's Stated Goal of Expanding its Clinical and Scientific Teams as it Progresses Development and Ultimate Commercialization of its SEAL™ Device to Treat Brain Aneurysms MILPITAS, Calif. , June 18, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately...Galaxy Therapeutics Completes Enrollment of Primary Cohort in Pivotal SEAL IT IDE Trial
MILPITAS, Calif., May 30, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the completion of enrollment in the primary cohort of its SEAL IT IDE trial. The trial's primary arm, known as...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Galaxy Therapeutics
Sign Up For FreeTo access detailed company insights
Galaxy Therapeutics is a clinical-phase startup focused on revolutionizing the treatment of brain aneurysms through innovative solutions inspired by nature. Their flagship product, the SEAL Embolization System, is a dual-layer intrasaccular flow diverter designed for various types of aneurysms. The company is led by experienced neurointerventionali... Read More
